Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer.
Rodenburg
C J
CJ
Dept. of Medical Oncology, Rotterdam Cancer Institute Daniel den Hoed Kliniek, The Netherlands.
Nooter
K
K
Herweijer
H
H
Seynaeve
C
C
Oosterom
R
R
Stoter
G
G
Verweij
J
J
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003524:Cyclosporins / Q000008:administration & dosage; D004341:Drug Evaluation; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014747:Vinblastine / Q000008:administration & dosage
D003524:Cyclosporins; D014747:Vinblastine